Category

Articles

Biopharma experts article
Articles
September 15, 2021

You’re looking for the wrong expert for your rare or orphan drug

Rhonda Hollingsworth  Vice President, Client Solutions, Optime Care  When choosing a specialty pharmacy (SP) for…
Read More
Articles
July 27, 2021

Your specialty pharmacy is underperforming. What do you do now?

When you launched your biopharmaceutical product for a rare condition several years ago, you believed…
Read More
Articles
May 18, 2021

hae day :-): Optimizing Care for Patients with Hereditary Angioedema

Now celebrating its 10th anniversary, hae day :-) is an awareness campaign that unites the…
Read More
Articles
April 27, 2021

Patient Experience Week: Addressing the Challenges of Patients Living with a Rare Disorder

Patient Experience Week (PX Week), April 26-30, 2021, is an annual event to celebrate the…
Read More
Articles
December 8, 2020

The Proven Model for Improving Clinical Trial Results During the Pandemic

The pharmaceutical industry has not escaped the impact of the COVID-19 crisis. Every phase of…
Read More
Articles
November 23, 2020

How to Build an Integrated Service Model for Rare and Orphan Drugs

Six Questions You Should Ask a Consultant Many drug manufacturers and healthcare consultants attempt to…
Read More
Articles
October 16, 2020

9 Steps to Improving Patient Access to Rare and Orphan Drugs

A conversation on eHealth Radio Recently, I had the privilege of a thought-provoking conversation on…
Read More
Caring in the time of COVID
Articles
September 22, 2020

How to Stay Focused on Rare and Orphan Disorders in the Time of COVID

4 Critical Success Factors for Manufacturers Before I became president and CEO of Optime Care,…
Read More
Products first means patients get left behind
Articles
August 20, 2020

Product First Means Patients Left Behind

A tale of too many patients. My family has a long history of alpha-1 antitrypsin…
Read More
scale vs. service
Articles
July 13, 2020

Scale vs. Service? Your rare drug demands both.

When developing a drug commercialization strategy, there’s a misconception that patient service and program scalability are mutually exclusive. The prevailing…
Read More